Recent studies have shown that although obesity is a risk factor for adverse events, diminished abdominal fat may reduce obesity-related disorders [32], because less deposition of abdominal fat can increase insulin sensitivity, reduce cardiovascular risks, as well as achieve relatively benign prognosis [33]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.